(Date:12/1/2008)...f the National Cancer Institute,s cancer registry ...experience delayed or incomplete radiation treatme...his suboptimal care can lead to worse outcomes. ,... College and colleagues found that among a nationa...ancer registry patients aged 65 and older, almost ...
(Date:12/1/2008)..., Dec. 1 MassMutual Retirement Ser...pport its increasing nonprofit business. Nonprofit...o last year. , , Dan Darby joined MassMutu...r the Western region. He reports to M. Palmer Whit... for MassMutual,s Retirement Services Division, wh...
(Date:12/1/2008)... 1 Senetek PLC,(OTC Bul...ed in the,development of technologies that target...at Dynamics Group AG, specialists in the fields of...and research with offices in Zurich,Bern and Gen.... , The Research Report, available in the "...
(Date:12/1/2008)...eroids effective against plantar fasciitis, resear...y News) -- Italian researchers say they,ve develop...he painful foot condition known as plantar fasciit... steroid injections guided by ultrasound, the rese...uccess rate in tackling a condition that afflicts ...
Breaking Medicine News(10 mins):Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 3Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3...genes which are active in prostate cancer have bee...el, cancer tissue differs markedly from normal hea...rchers have now developed the tools that can visua...characterise the cancerous cell. Using microarray ...
...dabad-based Zydus Cadila Healthcare announced a st...eting and manufacturing of formulation brands and ...n's anti-hypertensive drug 'Aten' for Rs. 75 crore...n the cardiovascular segment. Aten, today, ranks w...
...g to a study, loss of muscle is not an inevitable ...t make new muscle protein fast enough and thereby ...he University of California shows that muscle prot...n over 70. In fact there is no difference in muscl...
... new war brewing! Neither in the devastated NewYor...ere in the commercial capital of India --- Mumbai....rmaceutical industry of the country and the RDCA o...he latter is a member body of over 5,000 retail dr...
Other Medicine News:(Date:11/30/2008)... Dec. 1 Older adults wh... flow and a greater number of small blood vessels ...y at the annual meeting of the Radiological Societ...conducted at the University of North Carolina ( ... scans of older adults who exercise to brain scans...
(Date:11/28/2008)...8 Eli Lilly and Company,... Drug Application (sNDA) from,the U.S. Food and D...ne HCl),for the management of chronic pain. Lilly...alf of 2009, adding data from a recently completed... the knee. , The decision does not affect d...
(Date:11/26/2008)...n density, automation and intelligent clinical app...o an all new level , , CHICAGO, Ill., Nov. ... ( www.siemens.com/healthcare ) highlights the A...BVS)(1), the world,s first multi-use, automated v...ific Assembly and Annual Meeting of the Radiologic...
(Date:11/25/2008).... 25 Kleinert Kutz and ... the fifth U.S. hand transplant on Messina, New Yo...Jewish Hospital Hand Care Center on Monday, Novemb... and was completed shortly after 9 p.m. in a recor...com.com/cgi-bin/prnh/20081125/DC48555-a ) , (Ph...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Brooks 28R 29 Sports Launches BioMoGo Biodegradable Shoe 24331 1Brooks 28R 29 Sports Launches BioMoGo Biodegradable Shoe 24331 2Brooks 28R 29 Sports Launches BioMoGo Biodegradable Shoe 24331 3Most Americans Dont Know Better Fats Benefit Heart Health 24327 1Most Americans Dont Know Better Fats Benefit Heart Health 24327 2Most Americans Dont Know Better Fats Benefit Heart Health 24327 3CPEhr and Junior Achievement Prepare High School Students For the Workforce 24323 1CPEhr and Junior Achievement Prepare High School Students For the Workforce 24323 2CPEhr and Junior Achievement Prepare High School Students For the Workforce 24323 3The Palomino Group Announces Launch of Meeting Support Services Business Unit 24319 1The Palomino Group Announces Launch of Meeting Support Services Business Unit 24319 2The Palomino Group Announces Launch of Meeting Support Services Business Unit 24319 3...WIRE)--Jun 4, 2007 - Acorda,Therapeutics, Inc.(R) ...esented a "meta-analysis" or combined analysis of ...clerosis during a,poster session at the Americas C...) Meeting in Washington, D.C. on Saturday, June 2,...vement in Walking,Speed on the Timed 25 Foot Walk ...
...4, 2007 /PRNewswire-FirstCall/ --,Bionovo, Inc.,s ...2,results for the treatment of hot flashes associa...n were enrolled in the company,s,double-blind, pla...nopausal women with 50 or more moderate to severe ...ee treatment groups receiving,MF101 (5 grams/day),...
Other Medicine Technology:Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 2Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 3Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 5Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 12 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 11.0 mm and length 10 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 9 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 9 mm.
Medicine Products: